Literature DB >> 32147775

The far-reaching HAND of cART: cART effects on astrocytes.

Hemil Gonzalez1,2, Anthony Podany3, Lena Al-Harthi2, Jennillee Wallace4.   

Abstract

Following the introduction of combination antiretroviral therapy (cART), the morbidity and mortality from human immunodeficiency virus (HIV) infection has been drastically curtailed and HIV has now become a chronic manageable disease. Persons living with HIV (PLWH) are living longer and experiencing significant co-morbidities and conditions of aging. NeuroHIV, clinically defined as HIV-Associated Neurocognitive Disorders (HAND) and pathologically manifested by persistent inflammation in the CNS despite cART, is a significant co-morbid condition for PLWH. In the pre-cART era, HIV mediated much of the pathogenesis in the Central Nervous System (CNS); in the cART era, with low to undetectable viremia, other mechanisms may be contributing to persistent neuroinflammation. Emerging data point to the adverse effects at the cellular level of cART, independent of HIV. Astrocytes are the most abundant cells in the CNS, playing vital roles in maintaining CNS homeostasis (e.g. metabolic support to neurons, clearance of neurotransmitters, ion balance, modulation of synaptic functions and maintaining the structural integrity of the blood brain barrier (BBB). Therefore, any disruption of their function will have wide repercussions in the CNS. In this review, we will address current knowledge and gaps on the impact of antiretrovirals (ARVs) on astrocytes and physiologic consequences in the CNS. Understanding the status of this field, will provide a practical framework to elucidate the potential role of cART-mediated dysregulation of astrocytes in neuroHIV pathogenesis and inform therapeutic strategies that are "neuro-friendly". Graphical abstract CNS-penetrating cART have the potential to cause resting astrocytes to become activated into an A1 or neurotoxic phenotype. These cells can in turn secrete inflammatory cytokines that affect surrounding microglia macrophages, as well as neurotoxic factors that impact nearby neurons. In addition, impairment in the physiologic functions of astrocytes will result in altered BBB permeability and disrupted metabolic homeostasis. CNS=Central Nervous System; cART=combined antiretroviral therapy; BBB=blood brain barrier.

Entities:  

Keywords:  ARVs; Astrocytes; HAND; Neurotoxicity; cART

Mesh:

Substances:

Year:  2020        PMID: 32147775      PMCID: PMC7483784          DOI: 10.1007/s11481-020-09907-w

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   7.285


  168 in total

1.  Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.

Authors:  B Autran; G Carcelain; T S Li; C Blanc; D Mathez; R Tubiana; C Katlama; P Debré; J Leibowitch
Journal:  Science       Date:  1997-07-04       Impact factor: 47.728

2.  Updated research nosology for HIV-associated neurocognitive disorders.

Authors:  A Antinori; G Arendt; J T Becker; B J Brew; D A Byrd; M Cherner; D B Clifford; P Cinque; L G Epstein; K Goodkin; M Gisslen; I Grant; R K Heaton; J Joseph; K Marder; C M Marra; J C McArthur; M Nunn; R W Price; L Pulliam; K R Robertson; N Sacktor; V Valcour; V E Wojna
Journal:  Neurology       Date:  2007-10-03       Impact factor: 9.910

3.  Involvement of nitric oxide in the mitochondrial action of efavirenz: a differential effect on neurons and glial cells.

Authors:  Nadezda Apostolova; Haryes A Funes; Ana Blas-Garcia; Fernando Alegre; Miriam Polo; Juan V Esplugues
Journal:  J Infect Dis       Date:  2014-12-23       Impact factor: 5.226

4.  One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjects.

Authors:  Monica Airoldi; Mauro Zaccarelli; Luca Bisi; Teresa Bini; Andrea Antinori; Cristina Mussini; Francesca Bai; Giancarlo Orofino; Laura Sighinolfi; Andrea Gori; Fredy Suter; Franco Maggiolo
Journal:  Patient Prefer Adherence       Date:  2010-05-13       Impact factor: 2.711

5.  Rate and severity of HIV-associated dementia (HAD): correlations with Gp41 and iNOS.

Authors:  D C Adamson; J C McArthur; T M Dawson; V L Dawson
Journal:  Mol Med       Date:  1999-02       Impact factor: 6.354

6.  The antiretroviral protease inhibitor ritonavir accelerates glutathione export from cultured primary astrocytes.

Authors:  Christian Arend; Maria Brandmann; Ralf Dringen
Journal:  Neurochem Res       Date:  2013-01-23       Impact factor: 3.996

7.  Consequences of a Chronic Exposure of Cultured Brain Astrocytes to the Anti-Retroviral Drug Efavirenz and its Primary Metabolite 8-Hydroxy Efavirenz.

Authors:  Christian Arend; Alica Rother; Stefan Stolte; Ralf Dringen
Journal:  Neurochem Res       Date:  2016-09-21       Impact factor: 3.996

8.  Accelerated Tau deposition in the brains of individuals infected with human immunodeficiency virus-1 before and after the advent of highly active anti-retroviral therapy.

Authors:  Iain C Anthony; Stephen N Ramage; Frances W Carnie; Peter Simmonds; Jeanne E Bell
Journal:  Acta Neuropathol       Date:  2006-05-09       Impact factor: 17.088

9.  Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system.

Authors:  Cagla Akay; Michael Cooper; Akinleye Odeleye; Brigid K Jensen; Michael G White; Fair Vassoler; Patrick J Gannon; Joseph Mankowski; Jamie L Dorsey; Alison M Buch; Stephanie A Cross; Denise R Cook; Michelle-Marie Peña; Emily S Andersen; Melpo Christofidou-Solomidou; Kathryn A Lindl; M Christine Zink; Janice Clements; R Christopher Pierce; Dennis L Kolson; Kelly L Jordan-Sciutto
Journal:  J Neurovirol       Date:  2014-01-14       Impact factor: 2.643

10.  Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patients.

Authors:  Clotilde Allavena; Matthieu Hanf; David Rey; Claudine Duvivier; Firouze BaniSadr; Isabelle Poizot-Martin; Christine Jacomet; Pascal Pugliese; Pierre Delobel; Christine Katlama; Véronique Joly; Christian Chidiac; Nathalie Dournon; Dominique Merrien; Thierry May; Jacques Reynes; Amandine Gagneux-Brunon; Catherine Chirouze; Thomas Huleux; André Cabié; François Raffi
Journal:  PLoS One       Date:  2018-09-21       Impact factor: 3.240

View more
  6 in total

1.  Longitudinal Effects of Combination Antiretroviral Therapy on Cognition and Neuroimaging Biomarkers in Treatment-Naive People With HIV.

Authors:  Miriam T Weber; Alan Finkelstein; Md Nasir Uddin; Elizabeth Asiago Reddy; Roberto C Arduino; Lu Wang; Madalina E Tivarus; Jianhui Zhong; Xing Qiu; Giovanni Schifitto
Journal:  Neurology       Date:  2022-06-22       Impact factor: 11.800

Review 2.  Mechanisms of neuronal dysfunction in HIV-associated neurocognitive disorders.

Authors:  Elena Irollo; Jared Luchetta; Chunta Ho; Bradley Nash; Olimpia Meucci
Journal:  Cell Mol Life Sci       Date:  2021-02-13       Impact factor: 9.261

3.  Osteopontin/secreted phosphoprotein-1 behaves as a molecular brake regulating the neuroinflammatory response to chronic viral infection.

Authors:  Farina J Mahmud; Yong Du; Elizabeth Greif; Thomas Boucher; Robert F Dannals; William B Mathews; Martin G Pomper; Polina Sysa-Shah; Kelly A Metcalf Pate; Claire Lyons; Bess Carlson; Maria Chacona; Amanda M Brown
Journal:  J Neuroinflammation       Date:  2020-09-17       Impact factor: 8.322

4.  Triumeq Increases Excitability of Pyramidal Neurons in the Medial Prefrontal Cortex by Facilitating Voltage-Gated Ca2+ Channel Function.

Authors:  Lihua Chen; Lena Al-Harthi; Xiu-Ti Hu
Journal:  Front Pharmacol       Date:  2021-01-28       Impact factor: 5.810

5.  Blood-Brain Barrier Impairment in Patients Living with HIV: Predictors and Associated Biomarkers.

Authors:  Giulia Caligaris; Mattia Trunfio; Valeria Ghisetti; Jessica Cusato; Marco Nigra; Cristiana Atzori; Daniele Imperiale; Stefano Bonora; Giovanni Di Perri; Andrea Calcagno
Journal:  Diagnostics (Basel)       Date:  2021-05-12

Review 6.  Role of Inflammasomes in HIV-1 and Drug Abuse Mediated Neuroinflammaging.

Authors:  Susmita Sil; Fang Niu; Ernest T Chivero; Seema Singh; Palsamy Periyasamy; Shilpa Buch
Journal:  Cells       Date:  2020-08-08       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.